All marketing authorization holders of medicine are hereby informed that NMRA would not register new products of Sitagliptin Tablets 25mg and renew or issue import license for existing Sitagliptin Tablets 25mg.
- Details
All marketing authorization holders of medicine are hereby informed that NMRA would not register new products of Loratadine Dispersible Tablets and renew or issue import license for existing Loratadine Dispersible Tablets.
- Details
All marketing authorization holders of medicine are hereby informed that NMRA would not register new products of Azithromycin Tablets 1g and renew or issue import license for existing Azithromycin Tablets 1g.
- Details
All marketing authorization holders of medicine are hereby informed that NMRA would not register Olaparib Capsules.
- Details
All marketing authorization holders of medicine are hereby informed that NMRA would not register new products of Gentamicin containing topical preparations and renew or issue import license for existing Gentamicin containing topical preparations.
- Details